Please Note: This trial is no longer enrolling new participants
Evaluating the incidence and outcomes of patients with stage III non-small cell lung cancer (NSCLC) whose tumors harbor STK11 and/or Keap1 mutations treated with chemoradiation (CRT) followed by consolidation immunotherapy
| Protocol No. | CTO-IUSCC-0723 | Scope | Local |
|---|---|---|---|
| Principal Investigator | Nasser Hanna | Treatment Type | Retrospective |
| Age Group | Adult | Phase | NA |
